HTG -Clarifying Statement in relation to Activities Report Aug 3, 2021 ASX News Harvest Technology Group (ASX:HTG) Send Share Share
Incannex Completes Dosing Patients in Phase 2 Proof-of-Concept Trial of IHL-42X for the Treatment of Obstructive Sleep Apnoea Dec 20, 2021 | ASX News, Incannex Healthcare (ASX:IHL)
HTG : Appointment of Non-Executive Director Jul 8, 2021 | ASX News, Harvest Technology Group (ASX:HTG)
Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 | ASX News, Incannex Healthcare (ASX:IHL)